Viridian Therapeutics, Inc./DE Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Viridian Therapeutics, Inc./DE (VRDN) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 45.29 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-06
- Viridian Therapeutics, Inc./DE antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 32.71M shares, a 3.65% decline year-over-year.
- Viridian Therapeutics, Inc./DE antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 33.95M shares, a 8.46% increase year-over-year.
- Viridian Therapeutics, Inc./DE antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 31.30M shares, a 33.37% increase year-over-year.
- Viridian Therapeutics, Inc./DE antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 23.47M shares, a 12.11% increase year-over-year.
- Viridian Therapeutics, Inc./DE antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 29.86M shares, a 2.35% decline from fiscal 2024.
- Viridian Therapeutics, Inc./DE antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 30.58M shares, a 9.13% decline from fiscal 2023.
- Viridian Therapeutics, Inc./DE antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 33.65M shares, a 52.55% increase from fiscal 2022.
- Viridian Therapeutics, Inc./DE antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 22.06M shares, a 4.13% decline from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 45.29M shares 10-Q · filed 2026-08-06 | |||||||
| 2026-03-31 | 32.71M shares 10-Q · filed 2026-05-05 | |||||||
| 2025-12-31 | 29.86M shares 10-K · filed 2026-02-26 | |||||||
| 2025-09-30 | 34.29M shares 10-Q · filed 2025-11-05 | |||||||
| 2025-06-30 | 33.71M shares 10-Q · filed 2026-08-06 | |||||||
| 2025-03-31 | 33.95M shares 10-Q · filed 2026-05-05 | |||||||
| 2024-12-31 | 30.58M shares 10-K · filed 2026-02-26 | |||||||
| 2024-09-30 | 30.79M shares 10-Q · filed 2025-11-05 | |||||||
| 2024-06-30 | 31.89M shares 10-Q · filed 2025-08-06 | |||||||
| 2024-03-31 | 31.30M shares 10-Q · filed 2025-05-06 | |||||||
| 2023-12-31 | 33.65M shares 10-K · filed 2026-02-26 | |||||||
| 2023-09-30 | 23.76M shares 10-Q · filed 2024-11-12 | |||||||
| 2023-06-30 | 23.91M shares 10-Q · filed 2024-08-08 | 23.55M shares 10-Q · filed 2023-08-08 | ||||||
| 2023-03-31 | 23.47M shares 10-Q · filed 2024-05-08 | 23.10M shares 10-Q · filed 2023-05-10 | ||||||
| 2022-12-31 | 22.06M shares 10-K · filed 2025-03-03 | 22.06M shares 10-K · filed 2023-03-09 | ||||||
| 2022-09-30 | 21.77M shares 10-Q · filed 2023-11-13 | |||||||
| 2022-06-30 | 20.28M shares 10-Q · filed 2023-08-08 | |||||||
| 2022-03-31 | 20.94M shares 10-Q · filed 2023-05-10 | |||||||
| 2021-12-31 | 23.01M shares 10-K · filed 2024-02-27 | 23.01M shares 10-K · filed 2022-03-11 | ||||||
| 2021-09-30 | 26.77M shares 10-Q · filed 2022-11-14 | |||||||
| 2021-06-30 | 25.83M shares 10-Q · filed 2022-08-15 | |||||||
| 2021-03-31 | 27.25M shares 10-Q · filed 2022-05-13 | |||||||
| 2020-12-31 | 28.10M shares 10-K · filed 2022-03-11 | |||||||
| 2020-09-30 | 896.51K shares 10-Q · filed 2021-11-05 | 13.45M shares 10-Q · filed 2020-11-12 | ||||||
| 2020-06-30 | 846.32K shares 10-Q · filed 2021-08-12 | 12.70M shares 10-Q · filed 2020-08-05 | ||||||
| 2020-03-31 | 822.72K shares 10-Q · filed 2021-05-07 | 12.34M shares 10-Q · filed 2020-05-08 | ||||||
| 2019-12-31 | 236.00K shares 10-K · filed 2021-03-26 | 3.54M shares 10-K · filed 2020-03-13 | ||||||
| 2019-09-30 | 4.08M shares 10-Q · filed 2020-11-12 | |||||||
| 2019-06-30 | 4.54M shares 10-Q · filed 2020-08-05 | |||||||
| 2019-03-31 | 4.49M shares 10-Q · filed 2020-05-08 | |||||||
| 2018-12-31 | 3.58M shares 10-K · filed 2020-03-13 | |||||||
| 2018-09-30 | 3.57M shares 10-Q · filed 2019-11-08 | |||||||
| 2018-06-30 | 3.59M shares 10-Q · filed 2019-08-08 | |||||||
| 2018-03-31 | 2.91M shares 10-Q · filed 2019-05-09 | 3.51M shares 10-Q · filed 2018-05-09 | ||||||
| 2017-12-31 | 2.91M shares 10-K · filed 2019-03-14 | |||||||
| 2017-09-30 | 2.99M shares 10-Q · filed 2018-11-07 | |||||||
| 2017-06-30 | 3.03M shares 10-Q · filed 2018-08-08 | |||||||
| 2017-03-31 | 2.98M shares 10-Q · filed 2018-05-09 | |||||||
| 2016-12-31 | 15.42M shares 10-K · filed 2018-03-15 | 53.72K shares 10-K · filed 2017-03-24 | ||||||
| 2016-09-30 | 1.48M shares 10-Q · filed 2016-10-26 | 15.37M shares 10-Q · filed 2017-11-09 | 1.38M shares 10-Q · filed 2016-10-26 | |||||
| 2016-06-30 | 1.58M shares 10-Q · filed 2016-08-15 | 12.79M shares 10-Q · filed 2017-08-11 | 1.33M shares 10-Q · filed 2016-08-15 | |||||
| 2016-03-31 | 1.08M shares 10-Q · filed 2016-05-16 | |||||||
| 2015-12-31 | 12.77M shares 10-Q · filed 2017-05-11 | 966.75K shares 10-K · filed 2016-03-21 | ||||||
| 2015-09-30 | 982.77K shares 10-Q · filed 2016-10-26 | 896.38K shares 10-Q · filed 2016-10-26 | ||||||
| 2015-06-30 | 886.40K shares 10-Q · filed 2016-08-15 | 886.40M shares 10-Q · filed 2015-08-14 | 853.19K shares 10-Q · filed 2016-08-15 | 853.19M shares 10-Q · filed 2015-08-14 | ||||
| 2015-03-31 | 911.15K shares 10-Q · filed 2016-05-16 | |||||||
| 2014-12-31 | 849.70K shares 10-K · filed 2016-03-21 | |||||||
| 2014-09-30 | 741.40K shares 10-Q · filed 2015-11-13 | 274.59K shares 10-Q · filed 2015-11-13 | ||||||
| 2014-06-30 | 100.59M shares 10-Q · filed 2015-08-14 | 50.29M shares 10-Q · filed 2015-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |